Pfizer and biontech announce collaboration with brazil's eurofarma to manufacture covid-19 vaccine doses for latin america

New york, usa and mainz, germany, august 26, 2021 — pfizer inc. (nyse: pfe) and biontech se (nasdaq: bntx) today announced the signing of a letter of intent with eurofarma laboratÓrios sa, a brazilian biopharmaceutical company, to manufacture comirnaty® (covid-19 vaccine, mrna) (bnt162b2) for distribution within latin america.
BNTX Ratings Summary
BNTX Quant Ranking